MENU

SNDX Syndax Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of biopharmaceuticals for novel cancer therapies

Industry Biotechnology
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SNDX is expected to report earnings to fall 1.60% to -96 cents per share on March 05

Syndax Pharmaceuticals SNDX Stock Earnings Reports
Q4'24
Est.
$-0.96
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.11
Q1'24
Beat
by $0.14
Q4'23
Missed
by $0.03
The last earnings report on November 05 showed earnings per share of -98 cents, beating the estimate of -107 cents. With 697.58K shares outstanding, the current market capitalization sits at 1.16B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals for novel cancer therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
35 Gatehouse Drive
Phone
+1 781 419-1400
Employees
184
Web
https://www.syndax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

SNDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with ARVN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then ARVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
-1.16%
ARVN - SNDX
49%
Loosely correlated
+0.58%
ABOS - SNDX
47%
Loosely correlated
-0.51%
CRSP - SNDX
43%
Loosely correlated
+0.88%
KRYS - SNDX
42%
Loosely correlated
+0.85%
PGEN - SNDX
42%
Loosely correlated
+2.46%
More